Walgreens Boots Alliance, Inc. (WBA) Analysts See $1.48 EPS

June 19, 2018 - By Dolores Ford

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Logo

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.48 EPS on June, 28 before the open.They anticipate $0.15 EPS change or 11.28 % from last quarter’s $1.33 EPS. WBA’s profit would be $1.47 billion giving it 10.84 P/E if the $1.48 EPS is correct. After having $1.73 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see -14.45 % EPS growth. The stock increased 0.08% or $0.05 during the last trading session, reaching $64.2. About 723,520 shares traded. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has declined 21.33% since June 19, 2017 and is downtrending. It has underperformed by 33.90% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 12 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 8 have Buy rating, 0 Sell and 4 Hold. Therefore 67% are positive. Walgreens Boots Alliance had 14 analyst reports since December 20, 2017 according to SRatingsIntel. The company was maintained on Wednesday, March 28 by Guggenheim. RBC Capital Markets maintained Walgreens Boots Alliance, Inc. (NASDAQ:WBA) rating on Wednesday, March 28. RBC Capital Markets has “Buy” rating and $8800 target. The rating was maintained by Robert W. Baird with “Buy” on Thursday, January 4. The company was maintained on Wednesday, January 24 by Mizuho. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has “Buy” rating given on Tuesday, February 13 by Loop Capital Markets. The firm earned “Hold” rating on Wednesday, December 20 by SunTrust. The firm earned “Market Perform” rating on Wednesday, May 23 by Leerink Swann. SunTrust maintained the shares of WBA in report on Tuesday, April 17 with “Hold” rating. As per Friday, February 16, the company rating was maintained by RBC Capital Markets. On Monday, April 2 the stock rating was maintained by Scotia Capital with “Buy”.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $63.67 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 16.09 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

More news for Walgreens Boots Alliance, Inc. (NASDAQ:WBA) were recently published by: Seekingalpha.com, which released: “McKesson: Attractive At $150” on June 18, 2018. Seekingalpha.com‘s article titled: “Carreyrou, Bad Blood” and published on June 18, 2018 is yet another important article.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: